$55.72 +0.39(0.7%)
Tue Dec 2 14:15:00 EST

Johnson & Johnson (NYSE : JNJ)

Latest News

Page « Previous 1 2 3 4 5 6 Next »
Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation
Yesterday 9:00pmJohnson & Johnson

NEW BRUNSWICK, N.J. and SANTA BARBARA, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Johnson Johnson and Mentor Corporation , a leading supplier of medical products for the global aesthetic market, today announced a definitive agreement whereby Mentor will be acquired for approximately $1.07 billio...

Johnson & Johnson Begins Tender Offer to Acquire Omrix
Wednesday November 26, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Johnson Johnson is commencing today, through a new wholly-owned subsidiary, Binder Merger Sub, Inc., a cash tender offer to purchase all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. . Johnson Johnson reported on No...

Johnson & Johnson Begins Tender Offer to Acquire Omrix
Wednesday November 26, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Johnson Johnson is commencing today, through a new wholly-owned subsidiary, Binder Merger Sub, Inc., a cash tender offer to purchase all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. . Johnson Johnson reported on No...

Johnson & Johnson Begins Tender Offer to Acquire Omrix
Wednesday November 26, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Johnson Johnson is commencing today, through a new wholly-owned subsidiary, Binder Merger Sub, Inc., a cash tender offer to purchase all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. . Johnson Johnson reported on No...

Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Monday November 24, 2008Johnson & Johnson

NEW BRUNSWICK, N.J. and NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Johnson Johnson and Omrix Biopharmaceuticals, Inc. , a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced a definitive agreement whereby Omrix will be ac...

Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Monday November 24, 2008Johnson & Johnson

NEW BRUNSWICK, N.J. and NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Johnson Johnson and Omrix Biopharmaceuticals, Inc. , a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced a definitive agreement whereby Omrix will be ac...

Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Monday November 24, 2008Johnson & Johnson

NEW BRUNSWICK, N.J. and NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Johnson Johnson and Omrix Biopharmaceuticals, Inc. , a fully integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced a definitive agreement whereby Omrix will be ac...

Jury Awards $16.5 Million in Fentanyl Death Case
Tuesday November 18, 2008The Law Offices of Heygood, Orr, Reyes, Pearson & Bartolomei

CHICAGO, Nov. 17 /PRNewswire/ -- A jury in Chicago has found two Johnson Johnson subsidiaries liable in the death of a Cicero, Ill., woman who died while using a Duragesic(R) patch, and ordered the companies to pay her family $16,560,000.The verdict in the case involving 38-year-old Janice DiCos...

Deficit Sets A Record
Friday November 14, 2008Zacks.com: Analyst Blog

Remember when a federal budget deficit of $237.2 billion in a year would have been considered bad news? Well that was the budget deficit for just the month of October. That's right, the federal government took in $164.8 billion and spent $402 billion in the month of October. The budget de...

Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows
Wednesday November 12, 2008VISTAKON, Division of Johnson & Johnson Vision Care, Inc.

JACKSONVILLE, Fla., Nov. 12 /PRNewswire/ -- Soft contact lens wear does not result in clinically significant acceleration in the development of nearsightedness in children and does not cause relevant increases in axial length or corneal curvature, a new study shows. Findings from the three-year ...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
Monday November 10, 2008Seven Summits Investment Research

CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.Seven Summits Strategic Investments' PriceWatch Alerts are available athttp://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)Today's PriceW...

Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference
Friday November 7, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Johnson Johnson will participate in the Credit Suisse 2008 Health Care Conference on Thursday, Nov. 13, at the Arizona Biltmore Hotel. Donald M. Casey, Worldwide Chairman of Johnson Johnson's Comprehensive Care Group, will present in a sess...

Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
Thursday November 6, 2008VisionCare Ophthalmic Technologies, Inc.

SARATOGA, Calif., Nov. 5 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced that the American Journal of Ophthalmology (AJO), a premier peer-reviewed medical journ...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
Sunday November 2, 2008Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

SAN DIEGO, Nov. 1 /PRNewswire/ -- Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S. Psychiatric Mental Health Congress in ...

Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
Tuesday October 28, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Oct. 27 /PRNewswire-FirstCall/ -- As an initial step in the creation of a wellness and prevention business platform, Johnson Johnson announced today it has acquired HealthMedia, Inc., a privately held company located in Ann Arbor, Michigan, that creates web-based behavior ch...

Drug Store News' Retail Clinician Launches Debut Retail Clinician Family Health Edition With Support From McNeil Consumer Healthcare
Friday October 24, 2008Drug Store News

NEW YORK, Oct. 23 /PRNewswire/ -- Retail Clinician publishes, this month, a bonus edition of its quarterly magazine with an issue focused on the self-care revolution. This Special Issue was developed with support from McNeil Consumer Healthcare, a Johnson Johnson Consumer Products Company the p...

Vision-Related Quality of Life Benefits Improve More for Children Who Wear Contact Lenses Versus Glasses
Thursday October 23, 2008VISTAKON, division of Johnson & Johnson Vision Care, Inc.

ANAHEIM, Calif., Oct. 23 /PRNewswire/ -- Compared to glasses, contact lens wear offers improved vision-related quality of life benefits for children and teenagers. Findings from a multi-site, three-year study suggest that children who require vision correction should be given the option of being ...

Johnson & Johnson Reports 2008 Third-Quarter Results:
Tuesday October 14, 2008Johnson & Johnson

NEW BRUNSWICK, N.J., Oct. 14 /PRNewswire-FirstCall/ -- Johnson Johnson today announced sales of $15.9 billion for the third quarter of 2008, an increase of 6.4% as compared to the third quarter of 2007. Operational growth was 3.3% and the positive impact of currency was 3.1%. Domestic sales were...

Earnings results and economic reports - Week 42.
Sunday October 12, 2008StockWeb

Monday:Economic: NAEarnings: Fastenal (FAST), XL Cap (XL)Tuesday:Economic: NAEarnings: JJ (JNJ), Pepsi (PEP), Supervalu (SVU), WW Grainger (GWW), Altera (ALTR), CSX (CSX), Genentech (DNA), Intel (INTC), USANA (USNA)Wednesday:Economic: Weekly Crude,Earnings: BlackRock (BLK), C Schwab (SCHW), Coke (...

Page « Previous 1 2 3 4 5 6 Next »
Wed Dec 3 Markets Closed » Open in 0h0min